• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌中肥大细胞静息相关的预后特征

Mast Cells Resting-Related Prognostic Signature in Hepatocellular Carcinoma.

作者信息

Zhang Hao, Sun Lin, Hu Xiao

机构信息

Department of Hepatobiliary Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

Department of ICU, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

出版信息

J Oncol. 2021 Nov 18;2021:4614257. doi: 10.1155/2021/4614257. eCollection 2021.

DOI:10.1155/2021/4614257
PMID:34840569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8616659/
Abstract

The immune microenvironment of liver cancer is of great significance for the treatment of liver cancer. After evaluating the content of mast cells resting in the transcriptome data of The Cancer Genome Atlas database by CIBERSORT analysis, this study aimed to group the samples according to the content of mast cells resting in different samples to find the differentially expressed genes in the two groups. Significant prognostic differences were found between high and low mast cells resting infiltration groups. The prognostic model was constructed according to the differentially expressed genes. The model was validated using external independent datasets. The results revealed that the constructed model was reliable. It could well distinguish the prognostic differences of patients in different characteristic groups. The high-risk group was mainly concentrated in metabolic pathways. The risk score of this model was closely related to some immune cells, immune function, and immune checkpoints. Therefore, this model may provide new ideas for immunotherapy of hepatocellular carcinoma.

摘要

肝癌的免疫微环境对肝癌治疗具有重要意义。通过CIBERSORT分析评估癌症基因组图谱数据库转录组数据中静息肥大细胞的含量后,本研究旨在根据不同样本中静息肥大细胞的含量对样本进行分组,以找出两组中差异表达的基因。发现静息肥大细胞浸润高低组之间存在显著的预后差异。根据差异表达基因构建预后模型。使用外部独立数据集对该模型进行验证。结果显示构建的模型可靠。它能够很好地区分不同特征组患者的预后差异。高风险组主要集中在代谢途径。该模型的风险评分与一些免疫细胞、免疫功能和免疫检查点密切相关。因此,该模型可能为肝细胞癌的免疫治疗提供新思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5755/8616659/5533504f06b1/JO2021-4614257.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5755/8616659/c3211f7e75c9/JO2021-4614257.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5755/8616659/7c672ceb7054/JO2021-4614257.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5755/8616659/90f1f771a823/JO2021-4614257.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5755/8616659/c68853df0ce5/JO2021-4614257.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5755/8616659/5533504f06b1/JO2021-4614257.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5755/8616659/c3211f7e75c9/JO2021-4614257.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5755/8616659/7c672ceb7054/JO2021-4614257.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5755/8616659/90f1f771a823/JO2021-4614257.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5755/8616659/c68853df0ce5/JO2021-4614257.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5755/8616659/5533504f06b1/JO2021-4614257.005.jpg

相似文献

1
Mast Cells Resting-Related Prognostic Signature in Hepatocellular Carcinoma.肝细胞癌中肥大细胞静息相关的预后特征
J Oncol. 2021 Nov 18;2021:4614257. doi: 10.1155/2021/4614257. eCollection 2021.
2
Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.与肝细胞癌相关的预后和治疗性免疫特征的鉴定。
Cancer Cell Int. 2021 Feb 10;21(1):98. doi: 10.1186/s12935-021-01792-4.
3
A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer.与非小细胞肺癌预后相关的肿瘤免疫微环境基因特征
Oncol Rep. 2020 Mar;43(3):795-806. doi: 10.3892/or.2020.7464. Epub 2020 Jan 14.
4
Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.肝细胞癌肿瘤免疫微环境中与预后相关的糖酵解lncRNA特征的鉴定
Front Mol Biosci. 2021 Apr 22;8:645084. doi: 10.3389/fmolb.2021.645084. eCollection 2021.
5
Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.一种新型肝细胞癌免疫相关预后模型的开发与验证
J Transl Med. 2020 Feb 11;18(1):67. doi: 10.1186/s12967-020-02255-6.
6
Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma.新型免疫基因特征的系统表征预测肝细胞癌的预后因素
Front Cell Dev Biol. 2021 Sep 23;9:686664. doi: 10.3389/fcell.2021.686664. eCollection 2021.
7
Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma.肝细胞癌患者预后相关免疫基因的鉴定、验证及通路富集分析
Front Oncol. 2021 Sep 20;11:695001. doi: 10.3389/fonc.2021.695001. eCollection 2021.
8
Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures.糖酵解定义了具有不同突变特征和免疫浸润特征的肺腺癌的两个预后亚组。
Front Cell Dev Biol. 2021 Jul 22;9:645482. doi: 10.3389/fcell.2021.645482. eCollection 2021.
9
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.基于肝癌微环境构建风险评分预后模型。
World J Gastroenterol. 2020 Jan 14;26(2):134-153. doi: 10.3748/wjg.v26.i2.134.
10
Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma.肿瘤浸润免疫细胞的免疫特征可预测鳞状细胞癌的预后和治疗效果。
Int Immunopharmacol. 2020 Oct;87:106802. doi: 10.1016/j.intimp.2020.106802. Epub 2020 Jul 31.

引用本文的文献

1
Prognostic model construction and immune microenvironment analysis of pyroptosis-related genes in hepatocellular carcinoma based on single-cell RNA sequencing.基于单细胞RNA测序的肝细胞癌焦亡相关基因预后模型构建及免疫微环境分析
Front Immunol. 2025 Aug 21;16:1595539. doi: 10.3389/fimmu.2025.1595539. eCollection 2025.
2
The systematic analysis of genes related to butyrate metabolism suggests that CDKN3 could serve as a promising therapeutic target for lung adenocarcinoma treatment.对与丁酸代谢相关基因的系统分析表明,细胞周期蛋白依赖性激酶3(CDKN3)可能成为肺腺癌治疗的一个有前景的治疗靶点。
BMC Cancer. 2025 Jan 13;25(1):69. doi: 10.1186/s12885-024-13409-w.
3

本文引用的文献

1
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment.病毒性和自身免疫性肝病中的肝细胞癌:免疫微环境中 CD4+CD25+Foxp3+调节性 T 细胞的作用。
World J Gastroenterol. 2021 Jun 14;27(22):2994-3009. doi: 10.3748/wjg.v27.i22.2994.
2
Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response.遗传变异在 ABC 转运蛋白中的作用及其对乳腺癌预后和治疗反应的影响。
Int J Mol Sci. 2020 Dec 15;21(24):9556. doi: 10.3390/ijms21249556.
3
Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration.
Significance of Immune and Non-Immune Cell Stroma as a Microenvironment of Hepatocellular Carcinoma-From Inflammation to Hepatocellular Carcinoma Progression.
免疫和非免疫细胞基质作为肝癌微环境的意义——从炎症到肝癌进展。
Int J Mol Sci. 2024 Sep 24;25(19):10233. doi: 10.3390/ijms251910233.
4
RNA sequencing and multiplexed immunohistochemistry reveal the factors for postoperative recurrence of stage IB-IIA cervical squamous cell carcinoma.RNA测序和多重免疫组化揭示了IB-IIA期宫颈鳞状细胞癌术后复发的因素。
Discov Oncol. 2024 Sep 10;15(1):422. doi: 10.1007/s12672-024-01283-8.
5
Identification and Validation of Nicotinamide Metabolism-Related Gene Signatures as a Novel Prognostic Model for Hepatocellular Carcinoma.烟酰胺代谢相关基因特征作为肝细胞癌新型预后模型的鉴定与验证
Onco Targets Ther. 2024 May 28;17:423-438. doi: 10.2147/OTT.S464709. eCollection 2024.
6
A Novel Gene Signature based on Immune Cell Infiltration Landscape Predicts Prognosis in Lung Adenocarcinoma Patients.基于免疫细胞浸润景观的新型基因特征可预测肺腺癌患者的预后。
Curr Med Chem. 2024;31(38):6319-6335. doi: 10.2174/0109298673293174240320053546.
7
Machine learning-based disulfidptosis-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity in hepatocellular carcinoma.基于机器学习的二硫键相关 lncRNA 特征可预测肝细胞癌的预后、免疫浸润和药物敏感性。
Sci Rep. 2024 Feb 22;14(1):4354. doi: 10.1038/s41598-024-54115-8.
8
Prediction significance of autophagy-related genes in survival probability and drug resistance in diffuse large B-cell lymphoma.自噬相关基因对弥漫性大B细胞淋巴瘤生存概率和耐药性的预测意义
Aging (Albany NY). 2024 Jan 17;16(2):1049-1076. doi: 10.18632/aging.205282.
9
Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis.通过多层次生物信息学泛癌分析探究RKIP与YY1之间的相互作用
Cancers (Basel). 2023 Oct 11;15(20):4932. doi: 10.3390/cancers15204932.
10
Identification of a glycolysis-related miRNA Signature for Predicting Breast cancer Survival.鉴定与糖酵解相关的 miRNA 特征,用于预测乳腺癌患者的生存情况。
Mol Biotechnol. 2024 Aug;66(8):1988-2006. doi: 10.1007/s12033-023-00837-5. Epub 2023 Aug 3.
基于肿瘤免疫微环境探索的卵巢上皮癌预后标志物的鉴定。
Genomics. 2020 Nov;112(6):4827-4841. doi: 10.1016/j.ygeno.2020.08.027. Epub 2020 Sep 2.
4
KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma.KIF2C:在肝细胞癌发病机制中 Wnt/β-连环蛋白和 mTORC1 信号之间的新联系。
Protein Cell. 2021 Oct;12(10):788-809. doi: 10.1007/s13238-020-00766-y. Epub 2020 Aug 3.
5
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.葡萄糖-6-磷酸脱氢酶对于 K-Ras 驱动的肿瘤生长或转移并非必需。
Cancer Res. 2020 Sep 15;80(18):3820-3829. doi: 10.1158/0008-5472.CAN-19-2486. Epub 2020 Jul 13.
6
Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.宫颈癌中预后性miRNA特征及淋巴结转移相关关键基因的鉴定
Front Pharmacol. 2020 May 8;11:544. doi: 10.3389/fphar.2020.00544. eCollection 2020.
7
TCF 4 tumor suppressor: a molecular target in the prognosis of sporadic colorectal cancer in humans.TCF4 肿瘤抑制因子:人类散发性结直肠癌预后的分子靶点。
Cell Mol Biol Lett. 2020 Mar 31;25:24. doi: 10.1186/s11658-020-00217-w. eCollection 2020.
8
LncRNA SNHG6 plays an oncogenic role in colorectal cancer and can be used as a prognostic biomarker for solid tumors.LncRNA SNHG6 在结直肠癌中发挥致癌作用,可作为实体瘤的预后生物标志物。
J Cell Physiol. 2020 Oct;235(10):7620-7634. doi: 10.1002/jcp.29672. Epub 2020 Apr 2.
9
Identification and validation of immune-related lncRNA prognostic signature for breast cancer.鉴定和验证与免疫相关的长链非编码 RNA 预后标志物用于乳腺癌。
Genomics. 2020 May;112(3):2640-2646. doi: 10.1016/j.ygeno.2020.02.015. Epub 2020 Feb 19.
10
Kinesin Kif2C in regulation of DNA double strand break dynamics and repair.驱动蛋白 Kif2C 在调控 DNA 双链断裂动态变化和修复中的作用。
Elife. 2020 Jan 17;9:e53402. doi: 10.7554/eLife.53402.